Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir
Condition: Chronic Hepatitis B Interventions: Drug: Tenofovir alafenamide; Drug: Entecavir Sponsor: Chinese University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Kidney Disease | Hepatitis | Hepatitis B | Research | Urology & Nephrology | Viread